News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Big Investor Picks Up Large Stake In Allergan Inc. (AGN) To Push For Valeant Pharmaceuticals International (VRX) Merger



6/27/2014 6:52:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Hedge fund Paulson & Co has amassed a large stake in Allergan Inc (AGN.N) of more than 6 million shares and supports a deal between the Botox maker and Valeant Pharmaceuticals Inc (VRX.TO), people familiar with the matter said on Wednesday.

The position is expected to make the prominent U.S. hedge fund, led by John Paulson, one of the top 10 to 15 holders of Allergan, according to Thomson Reuters shareholder data as of March 31.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES